SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17591026
Source:
http://linkedlifedata.com/resource/pubmed/id/17591026
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0009429
,
umls-concept:C0016627
,
umls-concept:C0026809
,
umls-concept:C0029341
,
umls-concept:C0042769
,
umls-concept:C0556895
pubmed:issue
3
pubmed:dateCreated
2007-6-26
pubmed:abstractText
The clinical management of H5N1 influenza virus infection in humans remains unclear. Combination chemotherapy with drugs that target different viral proteins might be more effective than monotherapy.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/AI-57570
,
http://linkedlifedata.com/resource/pubmed/grant/AI-95357
,
http://linkedlifedata.com/resource/pubmed/grant/CA-21756
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9815705
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amantadine
,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Oseltamivir
pubmed:status
MEDLINE
pubmed:issn
1359-6535
pubmed:author
pubmed-author:GovorkovaElena AEA
,
pubmed-author:HoffmannErichE
,
pubmed-author:IlyushinaNatalia ANA
,
pubmed-author:SalomonRachelleR
,
pubmed-author:WebsterRobert GRG
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
363-70
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:17591026-Administration, Oral
,
pubmed-meshheading:17591026-Amantadine
,
pubmed-meshheading:17591026-Animals
,
pubmed-meshheading:17591026-Antiviral Agents
,
pubmed-meshheading:17591026-Dose-Response Relationship, Drug
,
pubmed-meshheading:17591026-Drug Evaluation, Preclinical
,
pubmed-meshheading:17591026-Drug Resistance, Viral
,
pubmed-meshheading:17591026-Drug Therapy, Combination
,
pubmed-meshheading:17591026-Female
,
pubmed-meshheading:17591026-Influenza A Virus, H5N1 Subtype
,
pubmed-meshheading:17591026-Mice
,
pubmed-meshheading:17591026-Mice, Inbred BALB C
,
pubmed-meshheading:17591026-Microbial Sensitivity Tests
,
pubmed-meshheading:17591026-Orthomyxoviridae Infections
,
pubmed-meshheading:17591026-Oseltamivir
pubmed:year
2007
pubmed:articleTitle
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
pubmed:affiliation
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't
,
Research Support, N.I.H., Extramural